Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients
Author(s) -
Tanqi Lou,
Jun Zhang,
Daniel P. Gale,
Andrew J. Rees,
Benjamin Rhodes,
John Feehally,
Caixia Li,
Youji Li,
Ru Li,
Weijun Huang,
Bin Hu,
Joseph C.K. Leung,
Man Fai Lam,
Kar Neng Lai,
Yiming Wang,
Patrick H. Maxwell
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp661
Subject(s) - medicine , nephropathy , genetic variation , etiology , gene , population , disease , immunology , genetics , biology , endocrinology , environmental health , diabetes mellitus
IgA nephropathy is a major cause of end-stage renal disease worldwide. Its aetiology is poorly understood but there is good evidence for a major genetic component, although to date, no gene has been conclusively identified. We describe a new UK multicentre DNA collection assembled to investigate this. A Japanese genome-wide analysis recently reported that common genetic variation in immunoglobulin mu-binding protein 2 (IGHMBP2) was associated with IgA nephropathy. We sought to replicate this using the new UK collection, and through an independent parallel analysis of a Han Chinese population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom